Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (12972)	1/2/1998 9:45:00 PM
From: Andrew H	Respond to of 32384

>>Sounds like "sky is falling" type of talk. Biotechs are high risk, and products will fail. But, he is talking about 1998. "Most" will fail?>> Well, squetch is the expert on "sky is falling" talk, but if you look at the number of compounds that begin P1 trials, I believe it is true that most (certainly more than 1/2) fail to get FDA approval. >>I've found before, when analysts say that the sky is falling; that is the time to buy! (selectively)<< I agree the article was fairly negative but there were a number of positive articles at the start of 1997 whose prophecies failed badly. Being a contrarian myself, I agree it is preferable when analysts are talking like this.